Skip to content

Clinical trials

Kidney Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Country / region: South Korea Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20121
20131
20152
20161
20172
20203
20212
20221
20234
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting7
Active, not recruiting4
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Seoul National University Hospital3
Asan Medical Center2
AstraZeneca2
Bayer2
Takeda2
Anthera Pharmaceuticals1
Dong-A ST Co., Ltd.1
Eli Lilly and Company1
HI-Bio, A Biogen Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases27
Glomerulonephritis9
Glomerulonephritis, IGA9
Urologic Diseases9
Renal Insufficiency, Chronic7
Autoimmune Diseases4
Diabetes Mellitus, Type 24
Nephritis4
Immune System Diseases3
Renal Insufficiency3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.